A carregar...

Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs

The high cost of drug development and the narrow spectrum of coverage typically provided by direct-acting antivirals limit the scalability of this antiviral approach. This review summarizes progress and challenges in the repurposing of approved kinase inhibitors as host-targeted broad-spectrum antiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:DNA Cell Biol
Main Authors: Schor, Stanford, Einav, Shirit
Formato: Artigo
Idioma:Inglês
Publicado em: Mary Ann Liebert, Inc. 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5804095/
https://ncbi.nlm.nih.gov/pubmed/29148875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/dna.2017.4033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!